NIDA is offering a grant to study nicotine’s effects on the immune system in the context of HIV-1 infection. Research should focus on the anti-inflammatory and protective properties of nicotine and their potential in reducing HIV-induced pathologies and associated CNS complications. The closing date for submissions is Jan 17, 2017.
Opportunity ID: 289602
General Information
Document Type: | Grants Notice |
Funding Opportunity Number: | RFA-DA-17-020 |
Funding Opportunity Title: | Nicotinic Immune Modulation in the Presence of HIV-1 Infection (R01) |
Opportunity Category: | Discretionary |
Opportunity Category Explanation: | – |
Funding Instrument Type: | Grant |
Category of Funding Activity: | Education Health |
Category Explanation: | – |
Expected Number of Awards: | 6 |
Assistance Listings: | 93.279 — Drug Abuse and Addiction Research Programs |
Cost Sharing or Matching Requirement: | No |
Version: | Synopsis 1 |
Posted Date: | Oct 19, 2016 |
Last Updated Date: | – |
Original Closing Date for Applications: | Jan 17, 2017 |
Current Closing Date for Applications: | Jan 17, 2017 |
Archive Date: | Feb 17, 2017 |
Estimated Total Program Funding: | $3,000,000 |
Award Ceiling: | – |
Award Floor: | – |
Eligibility
Eligible Applicants: | Native American tribal governments (Federally recognized) County governments Independent school districts Others (see text field entitled “Additional Information on Eligibility” for clarification) Public housing authorities/Indian housing authorities Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education City or township governments Private institutions of higher education Native American tribal organizations (other than Federally recognized tribal governments) State governments Special district governments Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Public and State controlled institutions of higher education Small businesses For profit organizations other than small businesses |
Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession. |
Additional Information
Agency Name: | National Institutes of Health |
Description: | The FOA encourages the submission of research project applications to determine nicotines modulatory effects on peripheral and central immune system functions in the presence of HIV-1 infection. Specifically, NIDA is particularly interested in projects exploring the ability of nicotine to produce anti-inflammatory and protective effects, and the translational potential of the new knowledge in attenuating HIV-induced pathologies and HIV-associated CNS complications such as neurological/cognitive disorders. |
Link to Additional Information: | http://grants.nih.gov/grants/guide/rfa-files/RFA-DA-17-020.html |
Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV Email:FBOWebmaster@OD.NIH.GOV |
Version History
Version | Modification Description | Updated Date |
---|---|---|
Related Documents
There are no related documents on this grant.
Packages
Agency Contact Information: | NIH OER Webmaster FBOWebmaster@OD.NIH.GOV Email: FBOWebmaster@OD.NIH.GOV |
Who Can Apply: | Organization Applicants |
Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
---|---|---|---|---|---|---|
FORMS-D | Use for due dates on or after May 25, 2016 | PKG00228694 | Dec 17, 2016 | Jan 17, 2017 | View |
Package 1
Mandatory forms
289602 RR_SF424_2_0-2.0.pdf
289602 PHS398_CoverPageSupplement_3_0-3.0.pdf
289602 RR_OtherProjectInfo_1_3-1.3.pdf
289602 PerformanceSite_2_0-2.0.pdf
289602 RR_KeyPersonExpanded_2_0-2.0.pdf
289602 PHS398_ResearchPlan_3_0-3.0.pdf
Optional forms
289602 RR_Budget_1_3-1.3.pdf
289602 RR_SubawardBudget30_1_3-1.3.pdf
289602 PHS398_ModularBudget_1_2-1.2.pdf
289602 PHS_Inclusion_Enrollment_Report-1.0.pdf
289602 PHS_AssignmentRequestForm-1.0.pdf